These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies. Deruelle P; Denervaud M; Hachulla E; Ducloy-Bouthors AS; Valat AS; Puech F; Trillot N; Hatron PY; Subtil D Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):73-8. PubMed ID: 16242833 [TBL] [Abstract][Full Text] [Related]
27. [Prevention of thrombosis during pregnancy: from recommendations to practice from 26 cases]. Epinat M; Buchmüller-Cordier A; Delsart D; Varlet MN; Laporte S; Epinat S; Decousus H; Mismetti P Therapie; 2002; 57(5):450-6. PubMed ID: 12611199 [TBL] [Abstract][Full Text] [Related]
28. Birth outcomes in pregnant women treated with low-molecular-weight heparin. Sørensen HT; Johnsen SP; Larsen H; Pedersen L; Nielsen GL; Møller M Acta Obstet Gynecol Scand; 2000 Aug; 79(8):655-9. PubMed ID: 10949230 [TBL] [Abstract][Full Text] [Related]
29. [Low-molecular weight heparin in the treatment of pregnant women with high thrombotic risk]. Todorova K; Mazneĭkova V; Ivanov S Akush Ginekol (Sofiia); 2004; 43(4):46-52. PubMed ID: 15318544 [No Abstract] [Full Text] [Related]
30. [Pregnancy and anticoagulant therapy. Indications and strategies]. Almange C; Schleich JM; Laurent M Arch Mal Coeur Vaiss; 2000 May; 93(5):613-8. PubMed ID: 10858859 [TBL] [Abstract][Full Text] [Related]
31. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin. Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303 [TBL] [Abstract][Full Text] [Related]
32. [Prevention and treatment of thrombosis in pregnancy]. Winkler UH; Schindler AE Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):301-12. PubMed ID: 8766488 [TBL] [Abstract][Full Text] [Related]
33. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: case report and a review of options for anticoagulation. Mahesh B; Evans S; Bryan AJ J Heart Valve Dis; 2002 Sep; 11(5):745-50. PubMed ID: 12358414 [TBL] [Abstract][Full Text] [Related]
34. Anticoagulation in pregnant women with prosthetic heart valves. Danik S; Fuster V Mt Sinai J Med; 2004 Oct; 71(5):322-9. PubMed ID: 15543433 [TBL] [Abstract][Full Text] [Related]
35. Heparins, low-molecular-weight heparins, and pentasaccharides. Dinwoodey DL; Ansell JE Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464 [TBL] [Abstract][Full Text] [Related]
36. [Anticoagulation in patients with heart valve replacement in pregnancy]. Harenberg J Z Kardiol; 1998; 87 Suppl 4():63-7. PubMed ID: 9857469 [TBL] [Abstract][Full Text] [Related]
37. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Gerhardt A; Zotz RB; Stockschlaeder M; Scharf RE Thromb Haemost; 2007 Mar; 97(3):496-7. PubMed ID: 17334521 [No Abstract] [Full Text] [Related]
38. [Thrombosis prophylaxis with heparins in intensive care patients]. Greinacher A; Janssen D Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Mar; 40(3):156-63. PubMed ID: 15770559 [TBL] [Abstract][Full Text] [Related]
39. [Current indications of low-molecular-weight heparins]. Vignes S; Meyer G; Marjanovic Z; Farge-Bancel D Ann Med Interne (Paris); 1997; 148(2):154-62. PubMed ID: 9238441 [TBL] [Abstract][Full Text] [Related]